Robert Silver

Background

About Robert Silver

One of the most active intellectual property litigators in the country and formerly Chairperson of Caesar Rivise’s Litigation Department and ANDA Litigation Team, Robert Silver represents global and U.S. companies in a wide range of litigation. His litigation practice as lead counsel for large, world-wide generic companies has emphasized complex suits involving Abbreviated New Drug Applications (ANDA) containing Paragraph IV challenges under the Hatch-Waxman Act. Mr. Silver counsels clients on ANDA preparation and strategies and has prepared, tried, argued and settled ANDA litigation cases all over the country. In addition, during his over 30 years of practice, he has argued numerous patent appeals before the Court of Appeals for the Federal Circuit. On the patent side, Mr. Silver has been involved in U.S. and foreign prosecutions in the mechanical, chemical, pharmaceutical, biomedical and biotechnical disciplines. He has also had extensive experience in interferences, and inter partes and ex parte reexamination proceedings in the chemical field and has arbitrated patent matters as an Arbitrator for the American Arbitration Association. Mr. Silver is registered to practice before the United States Patent and Trademark Office (USPTO).